Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a
The Journal of general virology, 2018.
Ribavirin (RBV) has been used for the last 20 years to treat patients with chronic hepatitis C virus (HCV) infection. This pluripotent drug is believed to induce mutagenesis in HCV RNA. However, for cell-cultured HCV (HCVcc) this phenomenon has only been investigated in genotype 2a recombinants. Here we studied the mutations that develope...More
Full Text (Upload PDF)